Stockreport

ImmunityBio (IBRX) Climbs 7.3% as Firm Nears Development of ‘World Bank of NK Cells' [Yahoo! Finance]

ImmunityBio, Inc.  (IBRX) 
PDF ImmunityBio surged by 7.29 percent on Friday to finish at $8.39 apiece, as investors took heart from the company's optimism for the development of the “World Bank of Na [Read more]